kynurenine has been researched along with Epilepsy, Temporal Lobe in 5 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Epilepsy, Temporal Lobe: A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with kynurenine inhibited glutamatergic activity in non-seizure control samples but not in MTLE-HS samples." | 5.62 | Altered hippocampal kynurenine pathway metabolism contributes to hyperexcitability in human mesial temporal lobe epilepsy-hippocampal sclerosis. ( Banerjee Dixit, A; Banerjee, J; Chandra, PS; Dey, S; Doddamani, RS; Lalwani, S; Sharma, MC; Tripathi, M, 2021) |
| "Treatment with kynurenine inhibited glutamatergic activity in non-seizure control samples but not in MTLE-HS samples." | 1.62 | Altered hippocampal kynurenine pathway metabolism contributes to hyperexcitability in human mesial temporal lobe epilepsy-hippocampal sclerosis. ( Banerjee Dixit, A; Banerjee, J; Chandra, PS; Dey, S; Doddamani, RS; Lalwani, S; Sharma, MC; Tripathi, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dey, S | 4 |
| Dubey, V | 3 |
| Dixit, AB | 3 |
| Tripathi, M | 4 |
| Chandra, PS | 4 |
| Banerjee, J | 4 |
| Banerjee Dixit, A | 1 |
| Doddamani, RS | 1 |
| Sharma, MC | 1 |
| Lalwani, S | 1 |
| Natsume, J | 1 |
| Kumakura, Y | 1 |
| Bernasconi, N | 1 |
| Soucy, JP | 1 |
| Nakai, A | 1 |
| Rosa, P | 1 |
| Fedi, M | 1 |
| Dubeau, F | 1 |
| Andermann, F | 1 |
| Lisbona, R | 1 |
| Bernasconi, A | 1 |
| Diksic, M | 1 |
| Young, SN | 1 |
| Joseph, MH | 1 |
| Gauthier, S | 1 |
| Schwarcz, R | 1 |
| Du, F | 1 |
1 review available for kynurenine and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
Quinolinic acid and kynurenic acid in the mammalian brain.
Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; AIDS Dementia Complex; Animals; Aspartic Acid; Biological Tra | 1991 |
1 trial available for kynurenine and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy.
Topics: Adolescent; Adult; Aged; Amygdala; Atrophy; Cerebral Cortex; Epilepsy, Temporal Lobe; Female; Glucos | 2003 |
3 other studies available for kynurenine and Epilepsy, Temporal Lobe